Celltrion says an additional 50,000 L of bioreactor capacity will come online next year. Meanwhile, the Korean drugmaker is “undecided” on the location of a third biomanufacturing facility. A capacity expansion at Celltrion is close to completion, doubling the size of the firm’s first facility at its site in Songdo, Incheon, South Korea. “Celltrion is currently wrapping up steps to add 50,000 liters of expanded capacity to its first plant based in Incheon,” spokesperson Heewon Park told BioProcess Insider. Presently,…